News - Neureka

Broadening the Scope of Clinical Trials: The Changing Role of Real-World Evidence

The role that real-world evidence, and the data that feeds into it, play in the clinical trials arena is changing. For many years, drug developers and regulators have collected real-world data (RWD) on adverse events linked to newly approved medicines. However, this data has not played a significant role in developing or executing pre-approval clinical trials. The situation is now changing. “There’s always been a need to look at how drugs that are coming out of clinical trials behave in the real world,” Gracy Crane, International Regulatory Policy Lead for RWD at Roche in the U.K., told Inside Precision Medicine.

Ontario Brain Institute, Epilepsy Ottawa, Neureka® Partner to Make Technology More Accessible to People with Epilepsy

February 15, 2023

In a collaborative effort to improve the quality of life of people with neurological conditions, the Ontario Brain Institute, Epilepsy Ottawa, and Neureka® (Neureka AI) completed a groundbreaking community study to make epilepsy-management technology more accessible to Canadians. The study results showed significant increases in patients’ quality of life and health, with improved engagement with their care partners.

Service-disabled Veteran-owned Academy Medical Inc. Announces Distribution Agreement for Neureka® Products, Joins SUDEP Data Alliance

January 25, 2023

Academy Medical Inc. announced this week that the company has signed a distribution agreement with Novela Neurotechnologies Inc. DBA Neureka AI for Neureka® products.

SUDEP Data Alliance Founded to Develop Life-Saving Interventions for SUDEP

December 2, 2022

The SUDEP Data Alliance announces its creation of the world’s first open data network with a mission to accelerate the development of new life-saving interventions to prevent Sudden Unexpected Death in Epilepsy (SUDEP). Cofounded by Neureka® (Neureka AI) and Briya, the SUDEP Data Alliance provides unprecedented real-world data that unites a global community of researchers, nonprofits, mission-driven companies, and people impacted by epilepsy.

Neureka®️ Sleep Provides At-Home Monitoring for Epilepsy Patients with SUDEP Risk

Novela Neurotechnologies, a leading provider of continuous neurology care, has launched Neureka® Sleep, an AI-powered wearable sleep monitor, to bring peace of mind to epilepsy patients and their families who worry about nocturnal seizures, which may lead to Sudden Unexpected Death in Epilepsy (SUDEP).

Novela Neurotechnologies Acquires 510(k)-Cleared Seizure-Detection Assets from Brain Sentinel

Novela Neurotechnologies Inc., a digital health company specializing in continuous, data-driven epilepsy care, acquires the complete intellectual property (IP) portfolio of Brain Sentinel Inc., former manufacturer of the SeizureLink™ wearable and 510(k)-cleared seizure-monitoring SPEAC® System. The acquisition spans 58 patents and applications and positions Novela at the forefront of epilepsy care.

Novela Neurotech Joins the 2021 UCSF Rosenman Innovators

Novela Neurotech, a leader in remote neurological care based in Alameda, California, is selected as part of the 2021 cohort of the Rosenman Innovators. Based at the University of California, San Francisco (UCSF), Rosenman Innovators are a prestigious group of early-stage companies chosen for their innovative technologies and patient impact.

Novela Neurotech Joins Sofie’s Journey in a Strategic Partnership to Promote Epilepsy Awareness

Novela Neurotech, a digital healthcare company specializing in personalized remote care for epilepsy and other neurological conditions, announces a strategic partnership with Sofie’s Journey to promote epilepsy awareness and access to cutting-edge epilepsy care solutions.

Novela Neurotech Partners with Epilepsy Advocate Brain Ablaze in Memorable Motto Challenge to Raise Epilepsy Awareness

December 8, 2020

This year we partnered with Novela Neurotech to bring a bit of fun to our Epilepsy Awareness Month with our Memorable Motto Challenge. Novela Neurotech then used the motto “The Patients are the Experts!” in a wonderfully designed T-shirt hosted in our store.

Novela Neurotech's neureka® 2020 Epilepsy Challenge featured at IEEE Signal Processing in Medicine and Biology Symposium

December 5, 2020

To celebrate the 10th year of the symposium, we are collaborating with Novela Neurotech and NeuroTechX to host the neureka 2020 Epilepsy Challenge.

Novela Neurotech to Present neureka® for Epilepsy Platform at Epilepsy Awareness Day at Disneyland

October 30, 2020

Novela Neurotech, a NeuroData company enabling personalized remote care for chronic neurological conditions, will showcase its nEureka® for Epilepsy smartwatch-based platform at the virtual Epilepsy Awareness Day at Disneyland (EADDL), November 2 at 9:30 AM PT.

Novela Neurotech to Present neureka® for Epilepsy Platform at CapCon 2020 Venture Conference

September 23, 2020

Novela Neurotech, a Data-as-a-Service company developing personalized remote epilepsy care using connected consumer data, will showcase its neureka® for Epilepsy platform at the virtual CapCon 2020 Venture Conference, Sep 29 to Oct 1, 2020.

Novela Neurotech Featured on Epilepsy Foundation NorCal's Research Spotlight

Research and development of new tools to fight and better understand seizures are critical aspects of our mutual goal to create a seizure-free world. We want to help organizations get your feedback and participation to shorten the time for those tools to get to market.

How a Crowdsourcing Challenge Turbocharged Brain Research During Lockdown

In mid-March, a trifecta of academic, non-profit, and commercial neurotech companies united to launch a neuroscientific challenge that embodied a more collaborative future for solving the brain, while physically apart and working from home.

Novela Neurotech Seeks to Accelerate Neurological Treatments with Brain Decoding as a Service

Novela Neurotech is a spin off from a Canadian university, the University of Waterloo. We have a long track record of university research and development in what we call the field of neuromodulation, which is basically a way to alter brain functions through different modalities, such as using electricity to change the way brain cells communicate.

“Biomed Irregulars” Won The First Place In nEureka Challenge!!!

A researcher team from STADIUS: “Biomed Irregulars” won the first place in Neureka Challenge!!! Neureka challenge was a month-long challenge organized by Novela Neurotech and NeuroTechX on seizure prediction using the TUH EEG Seizure dataset (one of the biggest available seizure datasets).

Novela Neurotech Appoints Aiman Abdel-Malek, Ph.D., to Board of Directors

As a highly experienced business strategic visionary leader, Dr. Abdel-Malek will support Novela in discovering dynaceutical therapies for brain disorders.

Novela Neurotech joins INCF's Industry Advisory Council to advance open neuroscience

By partnering with INCF, one of the world’s largest institutions promoting data and software reuse and reproducibility in brain research, Novela positions itself as an industry leader in neuroscience data sharing and collaboration.

Novela Featured in San Francisco Business Times: An Island of Innovation

Alameda is known for many things—among them, the monthly antiques fair, the former Naval Air Station and the U.S.S. Hornet, spirits distilleries, a vintage pinball museum, and as the birthplace of popsicles and creamy peanut butter.

Online Neureka™ challenge launches to crowdsource EEG solutions for epilepsy

Novela Neurotech and NeuroTechX are teaming up in an effort to accelerate epilepsy research

5 Top Emerging Neurotechnology Startups

The US-based startup Novela Neurotechnology builds Neureka, a smart platform to understand and decode neurological activity in the brain using artificial intelligence. Neureka, the startup’s platform combines smart neural interfaces and scheduled delivery of neuromodulation that results in accelerated drug discovery.

CRANIA to host collaborative neuromodulation workshop with Novela Neurotech and Hahn-Schickard

February 6, 2020

CRANIA, Novela Neurotech and Hahn-Schickard unites to accelerate the translation of Novela’s open source neuromodulation research kit.

Novela Neurotech teams up with UCSF to break down neurodata borders

February 4, 2020

Novela Neurotech teams up with UCSF to break down neurodata borders. Just as computer scientists developed standards to deliver digital content across the globe to your laptop, neuroscientists are working to break down barriers in data sharing.

Novela Neurotech begins testing wireless, read-write capable brain prosthesis

November 12, 2019

Consciousness is one of the brain’s most enigmatic mysteries. A new theory, inspired by thermodynamics, takes a high-level perspective of how neural networks in the brain transiently organize to give rise to memories, thought and consciousness.

Novela’s Neureka™ and the Future of Neurostimulation

“Neurostimulation is emerging as a novel non-pharmacological way of treating brain disorders and is showing far greater efficacy with fewer side effects.”

January 24, 2019

Novela’s hometown newspaper the Alameda Sun featured us in their Thursday 1/24/19 issue “Novela’s long-term vision is to extend memory and brain processing speed, and even to add built-in cloud connectivity as well as expand human senses.”